ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Beximco Pharma to manufacture molnupiravir for COVID-19
January 20, 2022The drug received conditional marketing authorisation in the UK from the MHRA in November -
Bangladesh signs Covid-19 vaccine deal with Serum Institute of India
November 09, 2020Bangladesh has entered into a deal with the Serum Institute of India (SII) to acquire 30 million doses of a potential vaccine being developed by AstraZeneca for Covid-19. -
Beximco signs deal with Serum Institute of India for COVID-19 vaccines
August 31, 2020Beximco Pharmaceuticals from Bangladesh announced investment in the Serum Institute of India (SII) for priority access to COVID-19 vaccines being developed by the Indian pharma manufacturer.
Pharma Sources Insight January 2025
